It has been reported that using RNA-guided CRISPR/Cas9 targeting HIV LTRs can eliminate integrated HIV-1 DNA from HIV-1-infected human CD4+ T cells, therefore leading to the inhibition of HIV infection [90]. Here, CD4 is linked to HIV infectious disease.